Skip to Main Content
Legislation Search

H.R. 3750: Fostering Operational Readiness through Continuous Evaluation of Fitness with Integrated Technology Act

This bill, titled the **Fostering Operational Readiness through Continuous Evaluation of Fitness with Integrated Technology Act** (or **FORCE-FIT Act**), aims to implement a pilot program under the TRICARE health care program for members of the Armed Forces. The primary focus of this pilot program is to provide continuous glucose monitoring technology to certain military personnel to track their metabolic health in real time. Here are the key components of the bill:

1. Pilot Program Implementation

The bill directs the Secretary of Defense to establish a pilot program to assess how real-time tracking of metabolic health and early interventions can:

  • Improve the health of military members.
  • Enhance force readiness.

2. Participation Requirements

Participation in this pilot program is mandatory for members identified as being in categories that signify they are either partially medically ready or not medically ready according to the **Individual Medical Readiness program**.

3. Data Collection and Usage

The health information collected from participants can only be used for specific purposes, such as:

  • Carrying out the pilot program.
  • Providing healthcare to the enrolled members.
  • Conducting the **Individual Medical Readiness program**.

Additionally, this information cannot be used for any adverse actions, such as discharging a service member from the Armed Forces. Non-governmental entities that provide technology or services under this pilot program must not retain health information after the authorized use is completed.

4. Provision of Information and Services

The Secretary of Defense is required to provide participating members with:

  • Information about metabolic health awareness.
  • Education and services aimed at improving force readiness.

5. Training for Medical Professionals

The bill mandates that medical professionals in military departments receive in-person training on the pilot program's procedures. Shared educational resources and training materials for all military departments must also be developed.

6. Program Duration

The pilot program is intended to run for a duration of five years.

7. Reporting Requirements

The bill stipulates that the **Comptroller General** and the Secretary of Defense must submit several reports regarding the pilot program:

  • Initial Report: Within three years of the program's start, a report comparing the medical readiness rates of participants before and during the program, along with recommendations for improvements.
  • Final Report: Within five years, a comprehensive assessment of the program’s effectiveness and recommendations for its future.

8. Definitions

The bill defines a **covered member** as a service member on active duty who meets specific health criteria, including:

  • Diagnosis of prediabetes.
  • Diagnosis of type 2 diabetes without insulin treatment.
  • History of gestational diabetes.
  • Individuals classified as overweight or obese.

It also references terms such as the **Individual Medical Readiness program** and the **TRICARE program** as established in previous legal frameworks.

Relevant Companies

  • MDGL (Madrigal Pharmaceuticals, Inc.): As a company involved in metabolic health research, this bill's focus on glucose monitoring may influence its product development and market opportunities.
  • ABT (Abbott Laboratories): Abbott produces continuous glucose monitoring systems and could see increased demand from military contracts following the bill's implementation.
  • VRTX (Vertex Pharmaceuticals Incorporated): As a biopharmaceutical company with an interest in diabetes treatments, any focus on monitoring may indirectly impact its research and development trajectories.

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

1 sponsor

Actions

2 actions

Date Action
Jun. 05, 2025 Introduced in House
Jun. 05, 2025 Referred to the House Committee on Armed Services.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

Estimated excess return of the underlying stock since the transaction
Politician Stock Transaction Filed Traded
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
May 12, 2025 Apr 23, 2025 -8.16%
Congress pfp
Bruce Westerman R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
May 12, 2025 Apr 21, 2025 -12.89%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
May 12, 2025 Apr 04, 2025 -10.05%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
May 12, 2025 Apr 04, 2025 -10.05%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
May 12, 2025 Apr 04, 2025 -10.05%
Congress pfp
Ro Khanna D / House
ABT logo
ABT -ABBOTT LABORATORIES
Sale $1,001 - $15,000
May 12, 2025 Apr 04, 2025 -10.05%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
May 12, 2025 Apr 04, 2025 -10.05%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
May 12, 2025 Apr 04, 2025 -10.05%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
May 12, 2025 Apr 04, 2025 -10.05%
Congress pfp
Byron Donalds R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Apr 14, 2025 Mar 20, 2025 +0.41%
Congress pfp
Byron Donalds R / House
VRTX logo
VRTX VERTEX PHARMACEUTICALS INCORPORATED - COMMON STOCK
Sale $1,001 - $15,000
Apr 14, 2025 Mar 20, 2025 -17.61%
Congress pfp
Byron Donalds R / House
VRTX logo
VRTX VERTEX PHARMACEUTICALS INCORPORATED - COMMON STOCK
Sale $1,001 - $15,000
Apr 14, 2025 Mar 20, 2025 -17.61%
Congress pfp
Byron Donalds R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Apr 14, 2025 Mar 20, 2025 +0.41%
Congress pfp
Jefferson Shreve R / House
VRTX logo
VRTX VERTEX PHARMACEUTICALS INCORPORATED - COMMON STOCK
Purchase $15,001 - $50,000
Apr 11, 2025 Mar 13, 2025 -19.07%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Sale $1,001 - $15,000
Apr 10, 2025 Mar 12, 2025 -3.77%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Sale $1,001 - $15,000
Apr 10, 2025 Mar 12, 2025 -3.77%
Congress pfp
Josh Gottheimer D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Apr 10, 2025 Mar 06, 2025 -4.82%
Congress pfp
Bruce Westerman R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Apr 16, 2025 Mar 03, 2025 -6.49%
Congress pfp
Shelley Moore Capito R / Senate
ABT logo
ABT Abbott Laboratories
Sale (Partial) $1,001 - $15,000
Mar 06, 2025 Feb 24, 2025 -0.43%
Congress pfp
Jefferson Shreve R / House
VRTX logo
VRTX VERTEX PHARMACEUTICALS INCORPORATED - COMMON STOCK
Purchase $15,001 - $50,000
Mar 09, 2025 Feb 24, 2025 -6.74%
Congress pfp
Josh Gottheimer D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Mar 06, 2025 Feb 13, 2025 +4.04%
Congress pfp
Josh Gottheimer D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Feb 10, 2025 Jan 29, 2025 +5.90%
Congress pfp
Josh Gottheimer D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Feb 10, 2025 Jan 28, 2025 +6.73%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Feb 06, 2025 Jan 17, 2025 +18.59%
Congress pfp
Jared Moskowitz D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Feb 10, 2025 Jan 15, 2025 +20.33%
Congress pfp
Jared Moskowitz D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Feb 10, 2025 Jan 15, 2025 +20.33%
Congress pfp
Jared Moskowitz D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Feb 10, 2025 Jan 15, 2025 +20.33%
Congress pfp
Markwayne Mullin R / Senate
ABT logo
ABT Abbott Laboratories
Sale (Full) $1,001 - $15,000
Jan 31, 2025 Jan 08, 2025 +16.43%
Congress pfp
Emily Randall D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Feb 11, 2025 Jan 06, 2025 +18.71%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Feb 06, 2025 Jan 02, 2025 +16.39%
Congress pfp
Thomas H. Kean, Jr. R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Jan 22, 2025 Dec 16, 2024 +21.00%
Congress pfp
Markwayne Mullin R / Senate
ABT logo
ABT Abbott Laboratories Common Stock
Sale (Partial) $15,001 - $50,000
Dec 31, 2024 Dec 11, 2024 +19.54%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABS
Sale $15,001 - $50,000
Dec 16, 2024 Nov 19, 2024 +13.62%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABS
Sale $15,001 - $50,000
Dec 16, 2024 Nov 19, 2024 +13.62%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Sale $15,001 - $50,000
Dec 05, 2024 Nov 12, 2024 +15.43%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABS
Purchase $50,001 - $100,000
Dec 16, 2024 Nov 04, 2024 +9.44%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABS
Purchase $50,001 - $100,000
Dec 16, 2024 Nov 04, 2024 +9.44%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABS
Purchase $50,001 - $100,000
Sep 16, 2024 Sep 09, 2024 +6.11%
Congress pfp
John James R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Sep 06, 2024 Sep 04, 2024 +9.06%
Congress pfp
Josh Gottheimer D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Sep 11, 2024 Aug 19, 2024 +13.41%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABS
Purchase $50,001 - $100,000
Sep 16, 2024 Aug 09, 2024 +11.57%
Congress pfp
Josh Gottheimer D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Aug 15, 2024 Jul 29, 2024 +18.70%
Congress pfp
Thomas H. Kean, Jr. R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Aug 19, 2024 Jul 23, 2024 +21.55%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Aug 07, 2024 Jul 18, 2024 +26.34%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Aug 07, 2024 Jul 18, 2024 +26.34%
Congress pfp
Jared Moskowitz D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Aug 19, 2024 Jul 05, 2024 +21.61%
Congress pfp
Kathy E. Manning D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Aug 16, 2024 Jul 02, 2024 +21.51%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Aug 07, 2024 Jul 02, 2024 +21.51%
Congress pfp
Kathy E. Manning D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Aug 16, 2024 Jul 02, 2024 +21.51%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Jun 05, 2024 May 29, 2024 +20.00%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Jun 05, 2024 May 20, 2024 +17.59%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Jun 05, 2024 May 20, 2024 +17.59%
Congress pfp
Tommy Tuberville R / Senate
VRTX logo
VRTX Vertex Pharmaceuticals Incorporated - Common Stock
Sale (Full) $1,001 - $15,000
Jun 14, 2024 May 03, 2024 -4.83%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
May 06, 2024 Apr 18, 2024 +8.04%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
May 06, 2024 Apr 18, 2024 +8.04%
Congress pfp
Kathy E. Manning D / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
Feb 06, 2024 Jan 23, 2024 -5.40%
Congress pfp
Kathy E. Manning D / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
Feb 06, 2024 Jan 23, 2024 -5.40%
Congress pfp
Thomas R. Carper D / Senate
ABT logo
ABT Abbott Laboratories
Sale (Partial) $1,001 - $15,000
Feb 02, 2024 Jan 17, 2024 -8.63%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Sale $1,001 - $15,000
Feb 05, 2024 Jan 10, 2024 -7.99%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Sale $1,001 - $15,000
Jan 04, 2024 Dec 05, 2023 -2.12%
Congress pfp
John R. Curtis R / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
Dec 15, 2023 Dec 04, 2023 -3.11%
Congress pfp
John James R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Sep 02, 2024 Nov 10, 2023 +7.40%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Nov 08, 2023 Oct 31, 2023 -0.83%
Congress pfp
Greg Stanton D / House
VRTX logo
VRTX VERTEX PHARMACEUTICALS INCORPORATED
Sale $1,001 - $15,000
Nov 09, 2023 Oct 24, 2023 -19.56%
Congress pfp
Greg Stanton D / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
Nov 09, 2023 Oct 24, 2023 +0.64%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $15,001 - $50,000
Nov 08, 2023 Oct 10, 2023 +0.19%
Congress pfp
Markwayne Mullin R / Senate
ABT logo
ABT Abbott Laboratories Common Stock
Purchase $1,001 - $15,000
Nov 01, 2023 Oct 03, 2023 -1.49%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Nov 08, 2023 Oct 02, 2023 +0.52%
Congress pfp
Greg Stanton D / House
ABT logo
ABT ABBOTT LABORATORIES
Purchase $1,001 - $15,000
Nov 09, 2023 Sep 26, 2023 -0.18%
Congress pfp
Pete Ricketts R / Senate
ABT logo
ABT Abbott Laboratories
Sale (Full) $100,001 - $250,000
Oct 20, 2023 Sep 21, 2023 -2.19%
Congress pfp
Markwayne Mullin R / Senate
ABT logo
ABT Abbott Laboratories Common Stock
Purchase $15,001 - $50,000
Oct 12, 2023 Sep 13, 2023 -2.99%
Congress pfp
John R. Curtis R / House
ABT logo
ABT ABBOTT LABORATORIES
Purchase $1,001 - $15,000
Oct 04, 2023 Sep 13, 2023 -2.99%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Sale $15,001 - $50,000
Oct 06, 2023 Sep 06, 2023 -1.63%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Sale $1,001 - $15,000
Sep 06, 2023 Sep 05, 2023 +0.20%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Sep 06, 2023 Aug 04, 2023 -9.05%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Sep 06, 2023 Aug 04, 2023 -9.05%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Sep 06, 2023 Aug 04, 2023 -9.05%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $15,001 - $50,000
Jul 11, 2023 Jun 29, 2023 -11.70%
Congress pfp
Ro Khanna D / House
VRTX logo
VRTX VERTEX PHARMACEUTICALS INCORPO CMN
Purchase $1,001 - $15,000
Jul 11, 2023 Jun 29, 2023 -7.41%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Jul 11, 2023 Jun 26, 2023 -14.25%